Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Flynn

Showing results (901-910 of 1,011) with videos related to

Pageof 102
Sort By:
Vaccine|November 28, 2018
Increasing FIM2/3 antigen-content improves efficacy of Bordetella pertussis vaccines in mice in vivo without altering vaccine-induced human reactogenicity biomarkers in vitroAnne Marie Queenan, David J Dowling, Wing Ki Cheng, et al.
ACS Applied Materials & Interfaces|January 29, 2016
Site-Selective Passivation of Defects in NiO Solar Photocathodes by Targeted Atomic DepositionCory J Flynn, Shannon M McCullough, EunBi Oh, et al.
Frontiers in Aging Neuroscience|March 26, 2021
Persistent Dark Cones in Oligocone Trichromacy Revealed by Multimodal Adaptive Optics OphthalmoscopyJoanne Li, Tao Liu, Oliver J Flynn, et al.
Cancer|January 10, 2018
Phase 1/2 trial of temsirolimus and sorafenib in the treatment of patients with recurrent glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572David Schiff, Kurt A Jaeckle, S Keith Anderson, et al.
Cytogenetic and Genome Research|August 12, 2005
International Equine Gene Mapping Workshop Report: a comprehensive linkage map constructed with data from new markers and by merging four mapping resourcesM C T Penedo, L V Millon, D Bernoco, et al.
Science Translational Medicine|January 12, 2022
Deep immune phenotyping reveals similarities between aging, Down syndrome, and autoimmunityKatharina Lambert, Keagan G Moo, Azlann Arnett, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2013
IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosisEmily Hams, Michelle E Armstrong, Jillian L Barlow, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 16, 2019
Quantitative Imaging Markers of Lung Function in a Smoking Population Distinguish COPD Subgroups with Differential Lung Cancer RiskChristine M Lusk, Angela S Wenzlaff, Donovan Watza, et al.
Clinical Breast Cancer|December 31, 2005
Two concurrent phase II trials of paclitaxel/carboplatin/trastuzumab (weekly or every-3-week schedule) as first-line therapy in women with HER2-overexpressing metastatic breast cancer: NCCTG study 983252Edith A Perez, Vera J Suman, Kendrith M Rowland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2010
Pain and emotional well-being outcomes in Southwest Oncology Group-directed intergroup trial S0205: a phase III study comparing gemcitabine plus cetuximab versus gemcitabine as first-line therapy in patients with advanced pancreas cancerCarol M Moinpour, Nancy L Vaught, Bryan Goldman, et al.
Pageof 102

Showing results (901-910 of 1,011) with videos related to

Sort By:
Pageof 102
Vaccine|November 28, 2018
Increasing FIM2/3 antigen-content improves efficacy of Bordetella pertussis vaccines in mice in vivo without altering vaccine-induced human reactogenicity biomarkers in vitroAnne Marie Queenan, David J Dowling, Wing Ki Cheng, et al.
ACS Applied Materials & Interfaces|January 29, 2016
Site-Selective Passivation of Defects in NiO Solar Photocathodes by Targeted Atomic DepositionCory J Flynn, Shannon M McCullough, EunBi Oh, et al.
Frontiers in Aging Neuroscience|March 26, 2021
Persistent Dark Cones in Oligocone Trichromacy Revealed by Multimodal Adaptive Optics OphthalmoscopyJoanne Li, Tao Liu, Oliver J Flynn, et al.
Cancer|January 10, 2018
Phase 1/2 trial of temsirolimus and sorafenib in the treatment of patients with recurrent glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572David Schiff, Kurt A Jaeckle, S Keith Anderson, et al.
Cytogenetic and Genome Research|August 12, 2005
International Equine Gene Mapping Workshop Report: a comprehensive linkage map constructed with data from new markers and by merging four mapping resourcesM C T Penedo, L V Millon, D Bernoco, et al.
Science Translational Medicine|January 12, 2022
Deep immune phenotyping reveals similarities between aging, Down syndrome, and autoimmunityKatharina Lambert, Keagan G Moo, Azlann Arnett, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2013
IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosisEmily Hams, Michelle E Armstrong, Jillian L Barlow, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 16, 2019
Quantitative Imaging Markers of Lung Function in a Smoking Population Distinguish COPD Subgroups with Differential Lung Cancer RiskChristine M Lusk, Angela S Wenzlaff, Donovan Watza, et al.
Clinical Breast Cancer|December 31, 2005
Two concurrent phase II trials of paclitaxel/carboplatin/trastuzumab (weekly or every-3-week schedule) as first-line therapy in women with HER2-overexpressing metastatic breast cancer: NCCTG study 983252Edith A Perez, Vera J Suman, Kendrith M Rowland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2010
Pain and emotional well-being outcomes in Southwest Oncology Group-directed intergroup trial S0205: a phase III study comparing gemcitabine plus cetuximab versus gemcitabine as first-line therapy in patients with advanced pancreas cancerCarol M Moinpour, Nancy L Vaught, Bryan Goldman, et al.
Pageof 102